H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access.
H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.
H.R. 7024 - Tax Relief for American Families and Workers Act of 2024. - Support for the expansion of the current child tax credit and other policies.
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
Issues related to making over-the-counter Naloxone accessible and available.
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access in the Medicare, Medicaid and Marketplaces.
H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health and equity.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Duration: September 2, 2013
to
present
General Issues: Health Issues , Medicare/Medicaid , Pharmacy
Spending: about $2,530,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), U.S. Senate,, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Melanie Nathanson Policy Analyst, Sr. Policy Advsr. - Senator Bob Graham
Senior Legislative Assistant - Rep. Sander Levin
Megan Hauck Pd Intern, LC, Scheduler, LA, Pol. Advsr.-Sen. Don Nickles
Deputy Asst. Secretary - DHHS
Special Asst. to POTUS - White House
Sr. Policy Advisor - Senator Mitch McConnell
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 13.
Original Filing: 301549037.xml
Lobbying Issues
H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access.
H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.
H.R. 7024 - Tax Relief for American Families and Workers Act of 2024. - Support for the expansion of the current child tax credit and other policies.
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
Issues related to making over-the-counter Naloxone accessible and available.
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access in the Medicare, Medicaid and Marketplaces.
H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health and equity.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Dec. 31, 2023.
Original Filing: 301521050.xml
Lobbying Issues
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
Issues related to making over-the-counter Naloxone accessible and available.
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health and equity.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 7, 2023.
Original Filing: 301498382.xml
Lobbying Issues
Issues related to making over-the-counter Naloxone accessible and available.
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health and equity.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 5, 2023.
Original Filing: 301473314.xml
Lobbying Issues
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
1st Quarter, 2023
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 18, 2023.
Original Filing: 301454258.xml
Lobbying Issues
Issues related to improving mental health care access for plan members and Medicare beneficiaries.
Rules, Regulations and legislative policies related to the Medicare Advantage program.
Issues related to identifying and addressing social determinants of health.
Issues related to the insurance Marketplace and providing full and affordable coverage options.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2022
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 17, 2023.
Original Filing: 301429241.xml
Lobbying Issues
H.R. 2617 - The Consolidated Appropriations Act for FY 2023 - Issues related to improving coverage of mental and behavioral health services across federal health care programs.
P.L. 117-169 - The Inflation Reduction Act of 2022 - Health care elements of the bill including policies supporting extension of ARPA ACA subsidies.
H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for improving the mental health and SUD systems in the country.
Executive Orders related to ACA improvements, maternal health, supporting diversity and support for treating mental health and substance use disorders.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Support for Senate efforts to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2617 - The Consolidated Appropriations Act for FY 2023 - Issues related to improving coverage of mental and behavioral health services in Medicare and Medicaid.
P.L. 117-169 - The Inflation Reduction Act of 2022 - Health care elements of the bill including policies supporting extension of ARPA ACA subsidies and delay of the Trump-era Medicare Rebate Rule.
H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for improvements in Medicare and Medicaid with a focus on mental health and SUD treatment.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Support for Senate work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 8, 2022.
Original Filing: 301401992.xml
Lobbying Issues
P.L. 117-169 - The Inflation Reduction Act of 2022 - Health care elements of the bill including policies supporting extension of ARPA ACA subsidies.
H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for improving the mental health and SUD systems in the country.
Executive Orders related to ACA improvements, maternal health, supporting diversity and support for treating mental health and substance use disorders.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Support for Senate efforts to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
P.L. 117-169 - The Inflation Reduction Act of 2022 - Health care elements of the bill including policies supporting extension of ARPA ACA subsidies and delay of the Trump-era Medicare Rebate Rule.
H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for improvements in Medicare and Medicaid with a focus on mental health and SUD treatment.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Support for Senate work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 4, 2022.
Original Filing: 301377192.xml
Lobbying Issues
H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for improving the mental health and SUD systems in the country.
Senate Reconciliation Bill efforts focused on ACA improvements included in ARPA.
Executive Orders related to ACA improvements, maternal health, supporting diversity and support for treating mental health and substance use disorders.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Support for Senate efforts to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for improvements in Medicare and Medicaid with a focus on mental health and SUD treatment.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Support for Senate work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $50,000. The report was filed on April 18, 2022.
Original Filing: 301359295.xml
Lobbying Issues
H.R. 2471 - Consolidated Appropriations Act for FT 2022 - Issues related to pandemic response including telemedicine.
Executive Orders related to ACA improvements, maternal health, supporting diversity and support for treating mental health and substance use disorders.
H.R. 5376 - Build Back Better Act - continued support for issues related to extending the timeframe for ACA improvements and other health care provisions included in the American Rescue Plan.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Implementation of the No Surprises Act
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Executive Orders related to supporting maternal health in the Medicaid program.
H.R. 5376 - Build Back Better Act - continued support for issues related to extending the timeframe for ACA improvements and other health care provisions included in the American Rescue Plan.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine in the Medicare program.
Work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $50,000. The report was filed on Jan. 11, 2022.
Original Filing: 301321109.xml
Lobbying Issues
H.R. 5376 - Build Back Better Act - Issues related to extending the timeframe for ACA improvements and other health care provisions included in the American Rescue Plan.
H.R. 3684 - Infrastructure Investment and Jobs Act - Issues related to the delay of the Trump Era Medicare Rebate Rule.
S. 610 - Protecting Medicare and American Farmers Act - Issues related to ensuring stability in the Medicare program.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Implementation of the No Surprises Act
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376 - Build Back Better Act - Issues related to extending the timeframe for ACA improvements and other health care provisions included in the American Rescue Plan.
H.R. 3684 - Infrastructure Investment and Jobs Act - Issues related to the delay of the Trump Era Medicare Rebate Rule.
S. 610 - Protecting Medicare and American Farmers Act - Issues related to ensuring stability in the Medicare program.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine in the Medicare program.
Work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $50,000. The report was filed on Oct. 11, 2021.
Original Filing: 301297660.xml
Lobbying Issues
Build Back Better Act - Issues related to extending the timeframe for ACA improvements and other health care provisions included in the American Rescue Plan.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Implementation of the No Surprises Act
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Build Back Better Act - Issues related to extending the timeframe for ACA improvements and other health care provisions included in the American Rescue Plan.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine in the Medicare program.
Work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 15, 2021.
Original Filing: 301276840.xml
Lobbying Issues
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Implementation of the No Surprises Act
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine in the Medicare program.
Work to identify better supports for people with behavioral health issues and substance use disorder in Medicare.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 14, 2021.
Original Filing: 301253248.xml
Lobbying Issues
PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
S. 748 - Medicare Sequester Relief Act - supporting a delay of the Medicare sequester.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2020
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 12, 2021.
Original Filing: 301230032.xml
Lobbying Issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing, telemedicine, support of the nation's health care system, patients, families and their care providers.
H.R. 8406 - The HEROES Act (modified) - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
The Senate HEALS Act - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces for consumers based on the Massachusetts Model.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act -Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Implementation- Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act -Implementation- Issues related to funding for providers providing care for people with COVID-19.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers.
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing, telemedicine, support of the nation's health care system, patients, families and their care providers.
H.R. 8406 - The HEROES Act (modified) - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
The Senate HEALS Act - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces and Medicaid coverage for consumers based on the Massachusetts Model.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act -Implementation- Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Implementation- Issues related to funding for providers providing care for people with COVID-19.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 12, 2020.
Original Filing: 301208694.xml
Lobbying Issues
H.R. 8406 - The HEROES Act (modified) - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
The Senate HEALS Act - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
H.R. 8319 - Continuing Appropriations Act of 2021 - Issues related to the funding of community health centers.
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces for consumers based on the Massachusetts Model.
H.R. 6800 - The HEROES Act - Issues related to ensuring that plans and providers are able to ensure smooth care and payment for treatments and testing related to COVID-19. Also focusing on telemedicine and mental health strategies that have shown promise through the pandemic.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act -Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Implementation- Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act -Implementation- Issues related to funding for providers providing care for people with COVID-19.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers.
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 8406 - The HEROES Act (modified) - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
The Senate HEALS Act - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues.
H.R. 8319 - Continuing Appropriations Act of 2021 - Issues related to the funding of community health centers.
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces and Medicaid coverage for consumers based on the Massachusetts Model.
H.R. 6800 - The HEROES Act - Issues related to ensuring that plans and providers are able to ensure smooth care and payment for treatments and testing related to COVID-19. Also focusing on telemedicine and mental health strategies that have shown promise through the pandemic in both the Medicare and Medicaid programs.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act -Implementation- Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Implementation- Issues related to funding for providers providing care for people with COVID-19.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 3, 2020.
Original Filing: 301185283.xml
Lobbying Issues
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces for consumers based on the Massachusetts Model.
H.R. 6800 - The HEROES Act - Issues related to ensuring that plans and providers are able to ensure smooth care and payment for treatments and testing related to COVID-19. Also focusing on telemedicine and mental health strategies that have shown promise through the pandemic.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act -Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Implementation- Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act -Implementation- Issues related to funding for providers providing care for people with COVID-19.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers.
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces and Medicaid coverage for consumers based on the Massachusetts Model.
H.R. 6800 - The HEROES Act - Issues related to ensuring that plans and providers are able to ensure smooth care and payment for treatments and testing related to COVID-19. Also focusing on telemedicine and mental health strategies that have shown promise through the pandemic in both the Medicare and Medicaid programs.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act -Implementation- Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Implementation- Issues related to funding for providers providing care for people with COVID-19.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 12, 2020.
Original Filing: 301165528.xml
Lobbying Issues
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers.
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 8, 2020.
Original Filing: 301103834.xml
Lobbying Issues
H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax.
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers.
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 13, 2019.
Original Filing: 301064936.xml
Lobbying Issues
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers.
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 11, 2019.
Original Filing: 301044370.xml
Lobbying Issues
S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency.
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 9, 2019.
Original Filing: 301023559.xml
Lobbying Issues
Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD).
Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
Issues related to surprise billing and strategies for giving patients more information and peace of mind.
Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team.
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HHS proposed rules related the treatment of rebates in Medicare Part D.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 13, 2019.
Original Filing: 301004034.xml
Lobbying Issues
H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis.
S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on the private insurance market.
Legislative efforts to support market stabilization.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs.
S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 13, 2018.
Original Filing: 300985008.xml
Lobbying Issues
H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis.
S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on the private insurance market.
Legislative efforts to support market stabilization.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs.
S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 12, 2018.
Original Filing: 300964254.xml
Lobbying Issues
H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis.
S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on the private insurance market.
Legislative efforts to support market stabilization.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs.
S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 18, 2018.
Original Filing: 300948076.xml
Lobbying Issues
H.R. 1625 - Consolidated Appropriations Act of 2018 - Issues related to combating the opioid crisis and health insurance marketplace stability.
H.R. 1301/ P.L. 115-124 - Continuing Resolution of 2018 - Issues related to policies to combat the opioid crisis, Issues related to enhancing Medicare coverage for people with chronic conditions, working for the inclusion of policies focused on mental health and palliative care and the health insurance tax delay.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on insurance market stabilization.
Legislative efforts by Senators Alexander and Murray to support market stabilization.
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1625 - Consolidated Appropriations Act of 2018 - Issues related to combating the opioid crisis for Medicare beneficiaries and others.
H.R. 1301/ P.L. 115-124 - Continuing Resolution of 2018 - Issues related to policies to combat the opioid crisis, Issues related to enhancing Medicare coverage for people with chronic conditions, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
Issues related to curbing the abuse of opioids in the United States as they relate to entitlement coverage.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 15, 2018.
Original Filing: 300923646.xml
Lobbying Issues
H.R. 1 - Tax Cuts and Jobs Act - Policies related to the ending of the individual mandate in the individual marketplaces and treatment of the alternative minimum tax.
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on insurance market stabilization.
Legislative efforts by Senators Alexander and Murray to support market stabilization.
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
Issues related to curbing the abuse of opioids in the United States as they relate to entitlement coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 11, 2017.
Original Filing: 300902830.xml
Lobbying Issues
H.R. 1628 - The American Health Care Act - Issues related to the private insurance market and plans providing coverage in the individual market places and opioid abuse coverage and treatment.
Better Care Reconciliation Act (Senate Amendment to H.R. 1628) - Issues related to the private insurance market and plans providing coverage in the individual market places and opioid coverage and treatment.
Graham-Cassidy ACA Repeal and Replace proposal - Issues related to the private insurance market and plans providing coverage in the individual market places and opioid coverage and treatment.
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on insurance market stabilization.
Legislative efforts by Senators Alexander and Murray to support market stabilization.
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
Issues related to curbing the abuse of opioids in the United States as they relate to entitlement coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 13, 2017.
Original Filing: 300884290.xml
Lobbying Issues
H.R. 1628 - The American Health Care Act - Issues related to the private insurance market and plans providing coverage in the individual market places and opioid abuse coverage and treatment.
Better Care Reconciliation Act (Senate Amendment to H.R. 1628) - Issues related to the private insurance market and plans providing coverage in the individual market places and opioid coverage and treatment.
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on insurance market stabilization.
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
HHS regulations focused on insurance market stabilization.
Issues related to curbing the abuse of opioids in the United States as they relate to entitlement coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 17, 2017.
Original Filing: 300866438.xml
Lobbying Issues
S. Con Res. 3 - Budget Resolution for 2017 - Issues related to the affordable care act and its impact on the private insurance market.
H.R. 1628 - The American Health Care Act - Issues related to the private insurance market and plans providing coverage in the individual market places.
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
HHS regulations focused on insurance market stabilization.
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 870 - CHRONIC Care Act of 2017 - Issues related to enhancing Medicare coverage for people with chronic conditions. Also, working for the inclusion of policies focused on mental health and palliative care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to curbing the abuse of opioids in the United States.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 13, 2017.
Original Filing: 300846194.xml
Lobbying Issues
S. 3504 - Creating High Quality Results and Outcome Necessary to Improve Chronic Care Act of 2016 - Issues related to palliative care, telemedicine and other issues related to better serving Medicare beneficiaries.
PL - 114- 255 - 21st Century Cures Act. Provisions to include help fight against opioid abuse.
H.R. 5327 - Continuing Appropriations and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs.
S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse.
H.R. 5447 - the Small Business Health Care Relief Act - issues regarding allowing small business owners the option to allow employees to purchase insurance in the individual market and the impact policies would have on state based marketplaces (SBMs)
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Regulations on civil rights and non discrimination based on section 1557 of the ACA.
Issues related to ACA waivers - section 1332 of the law.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 3504 - Creating High Quality Results and Outcome Necessary to Improve Chronic Care Act of 2016 - Issues related to palliative care, telemedicine and other issues related to better serving Medicare beneficiaries.
PL - 114- 255 - 21st Century Cures Act. Provisions to include help fight against opioid abuse.
H.R. 5327 - Continuing Appropriations and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs for Medicare and Medicaid beneficiaries.
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform in Medicare and the private insurance market.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
PL - 114- 255 - 21st Century Cures Act. Provisions to include help fight against opioid abuse.
H.R. 5327 - Continuing Appropriations and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs.
S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 18, 2016.
Original Filing: 300829772.xml
Lobbying Issues
H.R. 5327 - Continuing Appropriatins and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs.
S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse.
H.R. 5447 - the Small Business Health Care Relief Act - issues regarding allowing small business owners the option to allow employees to purchase insurance in the individual market and the impact policies would have on state based marketplaces (SBMs)
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Regulations on civil rights and non discrimination based on section 1557 of the ACA.
Issues related to ACA waivers - section 1332 of the law.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5327 - Continuing Appropriatins and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs for Medicare and Medicaid beneficiaries.
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform in Medicare and the private insurance market.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5327 - Continuing Appropriatins and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs.
S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300814976.xml
Lobbying Issues
S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse.
H.R. 5447 - the Small Business Health Care Relief Act - issues regarding allowing small business owners the option to allow employees to purchase insurance in the individual market and the impact policies would have on state based marketplaces (SBMs)
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Regulations on civil rights and non discrimination based on section 1557 of the ACA.
Issues related to ACA waivers - section 1332 of the law.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform in Medicare and the private insurance market.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 14, 2016.
Original Filing: 300791543.xml
Lobbying Issues
Advance Notice of Methodologies Changes for (CY)2017 for MA, Part C and Part D payment policies and the 2017 call letter.
Issues related to stemming the opioid epidemic in America and solutions developed by BCBSMA to combat abuse.
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Regulations on civil rights and non discrimination based on section 1557 of the ACA.
Issues related to ACA waivers - section 1332 of the law.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advance Notice of Methodologies Changes for (CY)2017 for MA, Part C and Part D payment policies and the 2017 call letter.
Work on alternative payment models developed by BCBSMA and how they can apply nationally.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform in Medicare and the private insurance market.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to stemming the opioid epidemic in America and solutions developed by BCBSMA to combat abuse.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 5, 2016.
Original Filing: 300769244.xml
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
H.R. 1624 - Protecting Affordable Care Coverage for Employees Act of 2015 - Focus of stabilizing insurance coverage for employers with 51-100 employees.
Protecting Americans from Tax Hikes (PATH) Act of 2015 (included as part of H.R. 2029 - the Consolidated Appropriations Act of 2016) - Provisions related to ACA-tax polices including the Health Insurance Tax and the " Cadillac" tax.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
Issues related to advancing policies to improve end of life care for seriously ill individuals.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to Medicare coverage.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 16, 2015.
Original Filing: 300754543.xml
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
H.R. 1624 - Protecting Affordable Care Coverage for Employees Act of 2015 - Focus of stabilizing insurance coverage for employers with 51-100 employees.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to Medicare coverage.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 15, 2015.
Original Filing: 300734636.xml
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
H.R. 2 - Medicare Access CHIP Reauthorization Act of 2015. Focus on policies modernizing physician payment systems and delivery system reform efforts across the board.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
H.R. 2 - Medicare Access CHIP Reauthorization Act of 2015. Focus on policies modernizing physician payment systems and delivery system reform efforts across the board.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to Medicare coverage.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - 21st Century Cures - Issues related to supporting programs to prevent opioid abuse in the Part D program.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 16, 2015.
Original Filing: 300717110.xml
Lobbying Issues
H.R. 2 - Medicare Access CHIP Reauthorization Act of 2015. Focus on policies modernizing physician payment systems and delivery system reform efforts across the board.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Issues related to Medicare coverage.
Issues related to post-enrollment support for newly insured.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2 - Medicare Access CHIP Reauthorization Act of 2015. Focus on policies modernizing physician payment systems and delivery system reform efforts across the board.
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to Medicare coverage.
Issues related to delivery system reform and innovation within the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to opioid abuse.
Issues related to state-based marketplaces.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 16, 2015.
Original Filing: 300698217.xml
Lobbying Issues
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to state-based insurance exchanges.
Issues related to Medicaid waivers.
Issues related to post-enrollment support for newly insured.
Issues related to innovation in the Medicare Advantage program.
Issues related to the 833(b) program for not-for-profit Blue plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to delivery system reform.
Issues related to opioid abuse.
Issues related to Medicaid waivers.
Issues related to innovation in the Medicare Advantage program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to curbing opioid abuse in the United States.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Oct. 14, 2014.
Original Filing: 300676249.xml
Lobbying Issues
H.R. 4994 - The IMPACT ACT - Issues related to the development of measurements to better include factors related to socioeconomic status to use for standard setting in the Medicare and Medicaid programs.
Issues related to delivery system and payment reform in both private insurance as well as the Medicare program
Issues related to the Massachusetts health insurance Exchange
Issues related to developing programs to decrease prescription drug abuse in America.
Issues related to post-enrollment support to newly insured individuals and families in the country.
Regulations impacting the Medicare Part C & D programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4994 - The IMPACT ACT - Issues related to the development of measurements to better include factors related to socioeconomic status to use for standard setting in the Medicare and Medicaid programs.
Issues related to delivery system and payment reform in both private insurance as well as the Medicare program
Issues related to the Massachusetts health insurance Exchange
Issues related to developing programs to decrease prescription drug abuse in America.
Regulations impacting the Medicare Part C & D programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to opioid abuse and programs that can successfully combat the problem.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on July 7, 2014.
Original Filing: 300653734.xml
Lobbying Issues
Issues related to Delivery System Reform.
Issues related to opioid abuse
Issues related to the implementation of the Affordable Care Act as they relate to insurance providers
Issues related to post-open enrollment support for the newly insured.Department of Health and Human Services Regulations impacting Medicare Part C&D
Department of Health and Human Services Regulations regarding the promulgation of myriad aspects of the implementation of the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to opioid abuse in the Medicare program
Department of Health and Human Services regulations governing payment and policies for Medicare Part C&D
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for
individuals with pain management needs.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on April 3, 2014.
Original Filing: 300632487.xml
Lobbying Issues
H.R. 4302 - Legislation to delay cuts to the sustained growth rate. Focus on ICD-10 delay provision.
Issues related to opioid abuse
Issues related to the implementation of the Affordable Care Act as they relate to insurance providers
Issues related to post-open enrollment support for the newly insuredCMS regulations related Medicare Part C&D
CMS Call letter regarding bids to participate in the Medicare Advantage and Part D programs for 2015
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CMS regulations related Medicare Part C&D
CMS Call letter regarding bids to participate in the Medicare Advantage and Part D programs for 2015
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for
individuals with pain management needs.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $60,000. The report was filed on Jan. 8, 2014.
Original Filing: 300611961.xml
Lobbying Issues
Amendment to H.J. Res 59 - Bipartisan Budget Relief Act - as it impacts Medicare and private insurance coverage
Issues related to opioid abuse
Issues related to the implementation of the Affordable Care Act as they relate to insurance providers
Issues related to the treatment of health insurance for postal workersHJ Res 59- Continuing Resolution legislation to allow the government to function and increase the debt limit- this negotiation has direct implications for payments to plans who participate in federally-funded insurance programs.
Issues related to the treatment of mental health in the Medicare, Medicaid and CHIP Programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HJ Res 59- Continuing Resolution legislation to allow the government to function and increase the debt limit- this negotiation has direct implications for payments to plans who participate in federally-funded insurance programs.
Issues related to the treatment of mental health in the Medicare, Medicaid and CHIP Programs
Amendment to H.J. Res 59- Bipartisan Budget Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for
individuals with pain management needs.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Nathanson+Hauck lobbied for Blue Cross Blue Shield of Massachusetts , earning $40,000. The report was filed on Oct. 15, 2013.
Original Filing: 300593669.xml
Lobbying Issues
H.R. 3204 - The Drug Quality and Security Act as it relates to safety of medications covered by BCBSMA
Issues related to opioid abuse
Issues related to the implementation of the Affordable Care Act as they relate to insurance providers
Issues related to the treatment of health insurance for postal workersHJ Res 59- Continuing Resolution legislation to allow the government to function and increase the debt limit- this negotiation has direct implications for payments to plans who participate in federally-funded insurance programs.
Issues related to the treatment of mental health in the Medicare, Medicaid and CHIP Programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HJ Res 59- Continuing Resolution legislation to allow the government to function and increase the debt limit- this negotiation has direct implications for payments to plans who participate in federally-funded insurance programs.
Issues related to the treatment of mental health in the Medicare, Medicaid and CHIP Programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3204 - The Drug Quality and Security Act as it relates to safety of medications covered by BCBSMA
Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for
individuals with pain management needs.
Agencies Lobbied
Health & Human Services - Dept of (HHS)
3rd Quarter, 2013
Nathanson+Hauck filed a lobbying registration on Sept. 12, 2013 to represent Blue Cross Blue Shield of Massachusetts, effective Sept. 2, 2013.
Original Filing: 300589818.xml
Issue(s) they said they’d lobby about: Issues related to health care coverage in both the public and private sectors. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...